{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:19:21Z","timestamp":1790957961684,"version":"4.1.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["7232260"],"award-info":[{"award-number":["7232260"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204369"],"award-info":[{"award-number":["82204369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-024-01428-1","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T06:46:30Z","timestamp":1732257990000},"page":"591-609","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["White matter lesions contribute to motor and non-motor disorders in Parkinson\u2019s disease: a critical review"],"prefix":"10.1007","volume":"47","author":[{"given":"Yue-Qi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Zhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Xia","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Rong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Qi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"issue":"6","key":"1428_CR1","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.neuron.2017.11.026","volume":"96","author":"C Sampaio-Baptista","year":"2017","unstructured":"Sampaio-Baptista C, Johansen-Berg H. White matter plasticity in the adult brain. Neuron. 2017;96(6):1239\u201351.","journal-title":"Neuron"},{"key":"1428_CR2","doi-asserted-by":"publisher","first-page":"117518","DOI":"10.1016\/j.jns.2021.117518","volume":"427","author":"E Fang","year":"2021","unstructured":"Fang E, Fartaria MJ, Ann CN, Mar\u00e9chal B, Kober T, Lim JX, Ooi LQR, Chen C, Lim SL, Tan EK, Chan LL. Clinical correlates of white matter lesions in Parkinson\u2019s disease using automated multi-modal segmentation measures. J Neurol Sci. 2021;427:117518.","journal-title":"J Neurol Sci"},{"issue":"12","key":"1428_CR3","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1212\/01.wnl.0000305959.46197.e6","volume":"70","author":"H Baezner","year":"2008","unstructured":"Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Langhorne P, O\u2019Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Hennerici MG. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology. 2008;70(12):935\u201342.","journal-title":"Neurology"},{"issue":"6","key":"1428_CR4","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/jcsm.12807","volume":"12","author":"N Ogama","year":"2021","unstructured":"Ogama N, Endo H, Satake S, Niida S, Arai H, Sakurai T. Impact of regional white matter hyperintensities on specific gait function in Alzheimer\u2019s disease and mild cognitive impairment. J Cachexia Sarcopenia Muscle. 2021;12(6):2045\u201355.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1428_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"18","author":"H Ye","year":"2023","unstructured":"Ye H, Robak LA, Yu M, Cykowski M, Shulman JM. Genetics and pathogenesis of Parkinson\u2019s syndrome. Annu Rev Pathol. 2023;18:95\u2013121.","journal-title":"Annu Rev Pathol"},{"key":"1428_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","volume":"226","author":"C Raza","year":"2019","unstructured":"Raza C, Anjum R, Shakeel NUA. Parkinson\u2019s disease: Mechanisms, translational models and management strategies. Life Sci. 2019;226:77\u201390.","journal-title":"Life Sci"},{"key":"1428_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fnagi.2018.00318","volume":"10","author":"KI Taylor","year":"2018","unstructured":"Taylor KI, Sambataro F, Boess F, Bertolino A, Dukart J. Progressive decline in gray and white matter integrity in de novo Parkinson\u2019s disease: an analysis of longitudinal parkinson progression markers initiative diffusion tensor imaging data. Front Aging Neurosci. 2018;10:318.","journal-title":"Front Aging Neurosci"},{"key":"1428_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neurobiolaging.2019.05.004","volume":"80","author":"LJ de Schipper","year":"2019","unstructured":"de Schipper LJ, Hafkemeijer A, Bouts M, van der Grond J, Marinus J, Henselmans JML, van Hilten JJ. Age- and disease-related cerebral white matter changes in patients with Parkinson\u2019s disease. Neurobiol Aging. 2019;80:203\u20139.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1428_CR9","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/STROKEAHA.121.035674","volume":"53","author":"P Kang","year":"2022","unstructured":"Kang P, Ying C, Chen Y, Ford AL, An H, Lee JM. Oxygen metabolic stress and white matter injury in patients with cerebral small vessel disease. Stroke. 2022;53(5):1570\u20139.","journal-title":"Stroke"},{"issue":"6","key":"1428_CR10","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/ana.26487","volume":"92","author":"D Lahna","year":"2022","unstructured":"Lahna D, Schwartz DL, Woltjer R, Black SE, Roese N, Dodge H, Boespflug EL, Keith J, Gao F, Ramirez J, Silbert LC. Venous collagenosis as pathogenesis of white matter hyperintensity. Ann Neurol. 2022;92(6):992\u20131000.","journal-title":"Ann Neurol"},{"key":"1428_CR11","doi-asserted-by":"publisher","first-page":"826812","DOI":"10.3389\/fimmu.2022.826812","volume":"13","author":"E He","year":"2022","unstructured":"He E, Liu M, Gong S, Fu X, Han Y, Deng F. White matter alterations in depressive disorder. Front Immunol. 2022;13:826812.","journal-title":"Front Immunol"},{"key":"1428_CR12","doi-asserted-by":"publisher","first-page":"9372050","DOI":"10.1155\/2017\/9372050","volume":"2017","author":"J Lin","year":"2017","unstructured":"Lin J, Wang D, Lan L, Fan Y. Multiple factors involved in the pathogenesis of white matter lesions. Biomed Res Int. 2017;2017:9372050.","journal-title":"Biomed Res Int"},{"key":"1428_CR13","doi-asserted-by":"publisher","first-page":"865920","DOI":"10.3389\/fneur.2022.865920","volume":"13","author":"F Meng","year":"2022","unstructured":"Meng F, Yang Y, Jin G. Research progress on MRI for white matter hyperintensity of presumed vascular origin and cognitive impairment. Front Neurol. 2022;13:865920.","journal-title":"Front Neurol"},{"issue":"7","key":"1428_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","volume":"18","author":"JM Wardlaw","year":"2019","unstructured":"Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684\u201396.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1428_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","volume":"74","author":"JM Starr","year":"2003","unstructured":"Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2003;74(1):70\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"1428_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1212\/WNL.0000000000003556","volume":"88","author":"CE Zhang","year":"2017","unstructured":"Zhang CE, Wong SM, van de Haar HJ, Staals J, Jansen JF, Jeukens CR, Hofman PA, van Oostenbrugge RJ, Backes WH. Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease. Neurology. 2017;88(5):426\u201332.","journal-title":"Neurology"},{"key":"1428_CR17","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3389\/fphys.2019.01269","volume":"10","author":"P Denver","year":"2019","unstructured":"Denver P, D\u2019Adamo H, Hu S, Zuo X, Zhu C, Okuma C, Kim P, Castro D, Jones MR, Leal C, Mekkittikul M, Ghadishah E, Teter B, Vinters HV, Cole GM, Frautschy SA. A novel model of mixed vascular dementia incorporating hypertension in a rat model of Alzheimer\u2019s disease. Front Physiol. 2019;10:1269.","journal-title":"Front Physiol"},{"issue":"3","key":"1428_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neurobiolaging.2007.07.015","volume":"30","author":"AJ Farrall","year":"2009","unstructured":"Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease\u2013systematic review and meta-analysis. Neurobiol Aging. 2009;30(3):337\u201352.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1428_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/jnen\/nlx009","volume":"76","author":"J Keith","year":"2017","unstructured":"Keith J, Gao FQ, Noor R, Kiss A, Balasubramaniam G, Au K, Rogaeva E, Masellis M, Black SE. Collagenosis of the deep medullary veins: an underrecognized pathologic correlate of white matter hyperintensities and periventricular infarction? J Neuropathol Exp Neurol. 2017;76(4):299\u2013312.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"1428_CR20","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1111\/ejn.15379","volume":"54","author":"A Rastogi","year":"2021","unstructured":"Rastogi A, Weissert R, Bhaskar SMM. Emerging role of white matter lesions in cerebrovascular disease. Eur J Neurosci. 2021;54(4):5531\u201359.","journal-title":"Eur J Neurosci"},{"key":"1428_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0022-510X(02)00283-6","volume":"203\u2013204","author":"WR Brown","year":"2002","unstructured":"Brown WR, Moody DM, Challa VR, Thore CR, Anstrom JA. Venous collagenosis and arteriolar tortuosity in leukoaraiosis. J Neurol Sci. 2002;203\u2013204:159\u201363.","journal-title":"J Neurol Sci"},{"issue":"5","key":"1428_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1755-5949.2010.00181.x","volume":"17","author":"A Assareh","year":"2011","unstructured":"Assareh A, Mather KA, Schofield PR, Kwok JB, Sachdev PS. The genetics of white matter lesions. CNS Neurosci Ther. 2011;17(5):525\u201340.","journal-title":"CNS Neurosci Ther"},{"issue":"12","key":"1428_CR23","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1161\/STROKEAHA.120.030343","volume":"51","author":"RJ Hack","year":"2020","unstructured":"Hack RJ, Rutten JW, Person TN, Li J, Khan A, Griessenauer CJ, Abedi V, LesnikOberstein SAJ, Zand R. Cysteine-altering NOTCH3 variants are a risk factor for stroke in the elderly population. Stroke. 2020;51(12):3562\u20139.","journal-title":"Stroke"},{"issue":"Pt 4","key":"1428_CR24","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/brain\/aww011","volume":"139","author":"JW Rutten","year":"2016","unstructured":"Rutten JW, Dauwerse HG, Peters DJ, Goldfarb A, Venselaar H, Haffner C, van Ommen GJ, Aartsma-Rus AM, LesnikOberstein SA. Therapeutic NOTCH3 cysteine correction in CADASIL using exon skipping: in vitro proof of concept. Brain. 2016;139(Pt 4):1123\u201335.","journal-title":"Brain"},{"issue":"2","key":"1428_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/CM9.0000000000001176","volume":"134","author":"JY Liu","year":"2020","unstructured":"Liu JY, Zhu YC, Zhou LX, Wei YP, Mao CH, Cui LY, Peng B, Yao M. HTRA1-related autosomal dominant cerebral small vessel disease. Chin Med J (Engl). 2020;134(2):178\u201384.","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"1428_CR26","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/jimd.12439","volume":"44","author":"H Padmanabha","year":"2021","unstructured":"Padmanabha H, Shekhar R, Mahale R, Annam H, Bhat M, Sangeeth TA, Christopher R, Arunachal G, Mailankody P, Mathuranath PS. Reversible leukoencephalopathy and cerebral atrophy in homocystinuria due to MTHFR deficiency: a treatable metabolic disorder. J Inherit Metab Dis. 2021;44(6):1505\u20136.","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"1428_CR27","doi-asserted-by":"publisher","first-page":"11352","DOI":"10.18632\/aging.202827","volume":"13","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Xiao X, Wen Y, Wan M, Zhou L, Liu X, Wang X, Guo L, Liu H, Zhou Y, Wang J, Liao X, Shen L, Jiao B. Genetic effect of MTHFR C677T, A1298C, and A1793G polymorphisms on the age at onset, plasma homocysteine, and white matter lesions in Alzheimer\u2019s disease in the Chinese population. Aging (Albany NY). 2021;13(8):11352\u201362.","journal-title":"Aging (Albany NY)"},{"key":"1428_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.neuroscience.2023.05.020","volume":"524","author":"C Li","year":"2023","unstructured":"Li C, Lu P, Zhang L, He Y, Zhang L, Yang L, Zhang F, Kong X, Tao Q, Zhou J, Wu J, Peng T, Xie B, Jiang Y, Peng J. Apolipoprotein E polymorphism impacts white matter injury through microglial phagocytosis after experimental subarachnoid hemorrhage. Neuroscience. 2023;524:220\u201332.","journal-title":"Neuroscience"},{"issue":"17","key":"1428_CR29","doi-asserted-by":"publisher","first-page":"e1812","DOI":"10.1212\/WNL.0000000000207113","volume":"100","author":"EC Gertje","year":"2023","unstructured":"Gertje EC, Janelidze S, van Westen D, Cullen N, Stomrud E, Palmqvist S, Hansson O, Mattsson-Carlgren N. Associations between CSF markers of inflammation, white matter lesions, and cognitive decline in individuals without dementia. Neurology. 2023;100(17):e1812\u201324.","journal-title":"Neurology"},{"issue":"4","key":"1428_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrneurol.2011.21","volume":"7","author":"NI Bohnen","year":"2011","unstructured":"Bohnen NI, Albin RL. White matter lesions in Parkinson disease. Nat Rev Neurol. 2011;7(4):229\u201336.","journal-title":"Nat Rev Neurol"},{"issue":"24","key":"1428_CR31","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1212\/WNL.0000000000007654","volume":"92","author":"RJ Cannistraro","year":"2019","unstructured":"Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF. CNS small vessel disease: a clinical review. Neurology. 2019;92(24):1146\u201356.","journal-title":"Neurology"},{"issue":"1","key":"1428_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0006-3495(94)80775-1","volume":"66","author":"PJ Basser","year":"1994","unstructured":"Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J. 1994;66(1):259\u201367.","journal-title":"Biophys J"},{"key":"1428_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neuroimage.2012.06.081","volume":"73","author":"DK Jones","year":"2013","unstructured":"Jones DK, Kn\u00f6sche TR, Turner R. White matter integrity, fiber count, and other fallacies: the do\u2019s and don\u2019ts of diffusion MRI. Neuroimage. 2013;73:239\u201354.","journal-title":"Neuroimage"},{"key":"1428_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/B978-0-12-800756-3.00046-6","volume-title":"Handbook of Cannabis and Related Pathologies","author":"N Solowij","year":"2017","unstructured":"Solowij N, Zalesky A, Lorenzetti V, Y\u00fccel M. Chapter 40 - Chronic Cannabis Use and Axonal Fiber Connectivity. In: Preedy VR, editor. Handbook of Cannabis and Related Pathologies. San Diego: Academic Press; 2017. p. 391\u2013400."},{"issue":"7","key":"1428_CR35","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s00415-018-8873-0","volume":"265","author":"T Minett","year":"2018","unstructured":"Minett T, Su L, Mak E, Williams G, Firbank M, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn D, O\u2019Brien JT. Longitudinal diffusion tensor imaging changes in early Parkinson\u2019s disease: ICICLE-PD study. J Neurol. 2018;265(7):1528\u201339.","journal-title":"J Neurol"},{"issue":"10","key":"1428_CR36","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1002\/hbm.24239","volume":"39","author":"V Pozorski","year":"2018","unstructured":"Pozorski V, Oh JM, Adluru N, Merluzzi AP, Theisen F, Okonkwo O, Barzgari A, Krislov S, Sojkova J, Bendlin BB, Johnson SC, Alexander AL, Gallagher CL. Longitudinal white matter microstructural change in Parkinson\u2019s disease. Hum Brain Mapp. 2018;39(10):4150\u201361.","journal-title":"Hum Brain Mapp"},{"key":"1428_CR37","doi-asserted-by":"publisher","first-page":"102098","DOI":"10.1016\/j.nicl.2019.102098","volume":"24","author":"Y-A Rau","year":"2019","unstructured":"Rau Y-A, Wang S-M, Tournier J-D, Lin S-H, Lu C-S, Weng Y-H, Chen Y-L, Ng S-H, Yu S-W, Wu Y-M, Tsai C-C, Wang J-J. A longitudinal fixel-based analysis of white matter alterations in patients with Parkinson\u2019s disease. NeuroImage: Clin. 2019;24:102098.","journal-title":"NeuroImage: Clin"},{"issue":"2","key":"1428_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/mds.28864","volume":"37","author":"PG Scamarcia","year":"2022","unstructured":"Scamarcia PG, Agosta F, Spinelli EG, Basaia S, Stojkovi\u0107 T, Stankovic I, Sarasso E, Canu E, Markovic V, Petrovi\u0107 I, Stefanova E, Pagani E, Kostic VS, Filippi M. Longitudinal white matter damage evolution in Parkinson\u2019s disease. Mov Disord. 2022;37(2):315\u201324.","journal-title":"Mov Disord"},{"issue":"3","key":"1428_CR39","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1212\/WNL.0000000000009890","volume":"95","author":"Y Lee","year":"2020","unstructured":"Lee Y, Ko J, Choi YE, Oh JS, Kim JS, Sunwoo MK, Yoon JH, Kang SY, Hong JY. Areas of white matter hyperintensities and motor symptoms of Parkinson disease. Neurology. 2020;95(3):e291\u20138.","journal-title":"Neurology"},{"issue":"2","key":"1428_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/1545968317753075","volume":"32","author":"MC Wen","year":"2018","unstructured":"Wen MC, Heng HSE, Lu Z, Xu Z, Chan LL, Tan EK, Tan LCS. Differential white matter regional alterations in motor subtypes of early drug-naive Parkinson\u2019s disease patients. Neurorehabil Neural Repair. 2018;32(2):129\u201341.","journal-title":"Neurorehabil Neural Repair"},{"key":"1428_CR41","doi-asserted-by":"publisher","first-page":"903469","DOI":"10.3389\/fncel.2022.903469","volume":"16","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang R, Awan MUN, Bai J. The mechanism and function of glia in Parkinson\u2019s disease. Front Cell Neurosci. 2022;16:903469.","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"1428_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41588-020-0610-9","volume":"52","author":"J Bryois","year":"2020","unstructured":"Bryois J, Skene NG, Hansen TF, Kogelman LJA, Watson HJ, Liu Z, Brueggeman L, Breen G, Bulik CM, Arenas E, Hjerling-Leffler J, Sullivan PF. Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson\u2019s disease. Nat Genet. 2020;52(5):482\u201393.","journal-title":"Nat Genet"},{"issue":"1","key":"1428_CR43","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1038\/s41467-020-17876-0","volume":"11","author":"D Agarwal","year":"2020","unstructured":"Agarwal D, Sandor C, Volpato V, Caffrey TM, Monz\u00f3n-Sandoval J, Bowden R, Alegre-Abarrategui J, Wade-Martins R, Webber C. A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders. Nat Commun. 2020;11(1):4183.","journal-title":"Nat Commun"},{"issue":"2","key":"1428_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/ane.13538","volume":"145","author":"V Siokas","year":"2022","unstructured":"Siokas V, Aloizou AM, Liampas I, Bakirtzis C, Tsouris Z, Sgantzos M, Liakos P, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. Myelin-associated oligodendrocyte basic protein rs616147 polymorphism as a risk factor for Parkinson\u2019s disease. Acta Neurol Scand. 2022;145(2):223\u20138.","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"1428_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/neup.12564","volume":"39","author":"T Kon","year":"2019","unstructured":"Kon T, Tanji K, Mori F, Kimura A, Kakita A, Wakabayashi K. Immunoreactivity of myelin-associated oligodendrocytic basic protein in Lewy bodies. Neuropathology. 2019;39(4):279\u201385.","journal-title":"Neuropathology"},{"issue":"12","key":"1428_CR46","doi-asserted-by":"publisher","first-page":"e2111405119","DOI":"10.1073\/pnas.2111405119","volume":"119","author":"C Azevedo","year":"2022","unstructured":"Azevedo C, Teku G, Pomeshchik Y, Reyes JF, Chumarina M, Russ K, Savchenko E, Hammarberg A, Lamas NJ, Collin A, Gouras GK, Klementieva O, Hallbeck M, Taipa R, Vihinen M, Roybon L. Parkinson\u2019s disease and multiple system atrophy patient iPSC-derived oligodendrocytes exhibit alpha-synuclein-induced changes in maturation and immune reactive properties. Proc Natl Acad Sci U S A. 2022;119(12):e2111405119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1428_CR47","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s00702-007-0790-9","volume":"114","author":"S Takagi","year":"2007","unstructured":"Takagi S, Hayakawa N, Kimoto H, Kato H, Araki T. Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice. J Neural Transm (Vienna). 2007;114(12):1553\u20137.","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"1428_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40478-017-0439-3","volume":"5","author":"J Grigoletto","year":"2017","unstructured":"Grigoletto J, Puka\u00df K, Gamliel A, Davidi D, Katz-Brull R, Richter-Landsberg C, Sharon R. Higher levels of myelin phospholipids in brains of neuronal \u03b1-Synuclein transgenic mice precede myelin loss. Acta Neuropathol Commun. 2017;5(1):37.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1428_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00726-021-03111-7","volume":"54","author":"V Martinsen","year":"2022","unstructured":"Martinsen V, Kursula P. Multiple sclerosis and myelin basic protein: insights into protein disorder and disease. Amino Acids. 2022;54(1):99\u2013109.","journal-title":"Amino Acids"},{"issue":"3","key":"1428_CR50","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/brain\/awab446","volume":"145","author":"S Smaji\u0107","year":"2022","unstructured":"Smaji\u0107 S, Prada-Medina CA, Landoulsi Z, Ghelfi J, Delcambre S, Dietrich C, Jarazo J, Henck J, Balachandran S, Pachchek S, Morris CM, Antony P, Timmermann B, Sauer S, Pereira SL, Schwamborn JC, May P, Gr\u00fcnewald A, Spielmann M. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain. 2022;145(3):964\u201378.","journal-title":"Brain"},{"issue":"3","key":"1428_CR51","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1212\/WNL.0000000000011155","volume":"96","author":"N Pyatigorskaya","year":"2021","unstructured":"Pyatigorskaya N, Yahia-Cherif L, Valabregue R, Gaurav R, Gargouri F, Ewenczyk C, Gallea C, Fernandez-Vidal S, Arnulf I, Vidailhet M, Lehericy S. Parkinson disease propagation using MRI biomarkers and partial least squares path modeling. Neurology. 2021;96(3):e460\u201371.","journal-title":"Neurology"},{"issue":"9","key":"1428_CR52","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1007\/s12035-018-0907-1","volume":"55","author":"AK Alieva","year":"2018","unstructured":"Alieva AK, Zyrin VS, Rudenok MM, Kolacheva AA, Shulskaya MV, Ugryumov MV, Slominsky PA, Shadrina MI. Whole-transcriptome analysis of mouse models with MPTP-induced early stages of Parkinson\u2019s disease reveals stage-specific response of transcriptome and a possible role of myelin-linked genes in neurodegeneration. Mol Neurobiol. 2018;55(9):7229\u201341.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"1428_CR53","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/mds.28891","volume":"37","author":"T Boshkovski","year":"2022","unstructured":"Boshkovski T, Cohen-Adad J, Misic B, Arnulf I, Corvol JC, Vidailhet M, Leh\u00e9ricy S, Stikov N, Mancini M. The myelin-weighted connectome in Parkinson\u2019s disease. Mov Disord. 2022;37(4):724\u201333.","journal-title":"Mov Disord"},{"issue":"9","key":"1428_CR54","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/mds.26251","volume":"30","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Wu IW, Buckley S, Coffey CS, Foster E, Mendick S, Seibyl J, Schuff N. Diffusion tensor imaging of the nigrostriatal fibers in Parkinson\u2019s disease. Mov Disord. 2015;30(9):1229\u201336.","journal-title":"Mov Disord"},{"key":"1428_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuroimage.2018.11.021","volume":"190","author":"D Meder","year":"2019","unstructured":"Meder D, Herz DM, Rowe JB, Leh\u00e9ricy S, Siebner HR. The role of dopamine in the brain - lessons learned from Parkinson\u2019s disease. Neuroimage. 2019;190:79\u201393.","journal-title":"Neuroimage"},{"key":"1428_CR56","first-page":"1","volume":"201","author":"H Braak","year":"2009","unstructured":"Braak H, Del Tredici K. Neuroanatomy and pathology of sporadic Parkinson\u2019s disease. Adv Anat Embryol Cell Biol. 2009;201:1\u2013119.","journal-title":"Adv Anat Embryol Cell Biol"},{"issue":"1","key":"1428_CR57","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mds.23455","volume":"26","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Stevens CH. Glia: initiators and progressors of pathology in Parkinson\u2019s disease. Mov Disord. 2011;26(1):6\u201317.","journal-title":"Mov Disord"},{"issue":"36","key":"1428_CR58","doi-asserted-by":"publisher","first-page":"14430","DOI":"10.1073\/pnas.0700901104","volume":"104","author":"H Inoue","year":"2007","unstructured":"Inoue H, Lin L, Lee X, Shao Z, Mendes S, Snodgrass-Belt P, Sweigard H, Engber T, Pepinsky B, Yang L, Beal MF, Mi S, Isacson O. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson\u2019s disease models. Proc Natl Acad Sci U S A. 2007;104(36):14430\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1428_CR59","doi-asserted-by":"publisher","first-page":"105988","DOI":"10.1016\/j.nbd.2023.105988","volume":"177","author":"C Ju","year":"2023","unstructured":"Ju C, Yuan F, Wang L, Zang C, Ning J, Shang M, Ma J, Li G, Yang Y, Chen Q, Jiang Y, Li F, Bao X, Zhang D. Inhibition of CXCR2 enhances CNS remyelination via modulating PDE10A\/cAMP signaling pathway. Neurobiol Dis. 2023;177:105988.","journal-title":"Neurobiol Dis"},{"issue":"8","key":"1428_CR60","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1523\/JNEUROSCI.2386-20.2021","volume":"41","author":"S Zhang","year":"2021","unstructured":"Zhang S, Wang Y, Zhu X, Song L, Zhan X, Ma E, McDonough J, Fu H, Cambi F, Grinspan J, Guo F. The Wnt effector TCF7l2 promotes oligodendroglial differentiation by repressing autocrine BMP4-mediated signaling. J Neurosci. 2021;41(8):1650\u201364.","journal-title":"J Neurosci"},{"issue":"39","key":"1428_CR61","doi-asserted-by":"publisher","first-page":"8163","DOI":"10.1523\/JNEUROSCI.2432-20.2021","volume":"41","author":"H Wang","year":"2021","unstructured":"Wang H, Liu M, Ye Z, Zhou C, Bi H, Wang L, Zhang C, Fu H, Shen Y, Yang JJ, Hu Y, Chen G. Akt regulates Sox10 expression to control oligodendrocyte differentiation via phosphorylating FoxO1. J Neurosci. 2021;41(39):8163\u201380.","journal-title":"J Neurosci"},{"issue":"3","key":"1428_CR62","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/glia.22281","volume":"60","author":"HM Guardiola-Diaz","year":"2012","unstructured":"Guardiola-Diaz HM, Ishii A, Bansal R. Erk1\/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation. Glia. 2012;60(3):476\u201386.","journal-title":"Glia"},{"issue":"6","key":"1428_CR63","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nn1460","volume":"8","author":"S Mi","year":"2005","unstructured":"Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci. 2005;8(6):745\u201351.","journal-title":"Nat Neurosci"},{"key":"1428_CR64","doi-asserted-by":"publisher","first-page":"106315","DOI":"10.1016\/j.nbd.2023.106315","volume":"187","author":"M Boccazzi","year":"2023","unstructured":"Boccazzi M, Macchiarulo G, Lebon S, Janowska J, Le Charpentier T, Faivre V, Hua J, Marangon D, Lecca D, Fumagalli M, Mani S, Abbracchio MP, Gressens P, Schang AL, Van Steenwinckel J. G protein-coupled receptor 17 is regulated by WNT pathway during oligodendrocyte precursor cell differentiation. Neurobiol Dis. 2023;187:106315.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"1428_CR65","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1002\/jcb.26654","volume":"119","author":"N Li","year":"2018","unstructured":"Li N, Han J, Tang J, Ying Y. IGFBP-7 inhibits the differentiation of oligodendrocyte precursor cells via regulation of Wnt\/\u03b2-Catenin signaling. J Cell Biochem. 2018;119(6):4742\u201350.","journal-title":"J Cell Biochem"},{"issue":"10","key":"1428_CR66","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1002\/glia.22848","volume":"63","author":"HK Lee","year":"2015","unstructured":"Lee HK, Laug D, Zhu W, Patel JM, Ung K, Arenkiel BR, Fancy SP, Mohila C, Deneen B. Apcdd1 stimulates oligodendrocyte differentiation after white matter injury. Glia. 2015;63(10):1840\u20139.","journal-title":"Glia"},{"key":"1428_CR67","doi-asserted-by":"publisher","first-page":"914153","DOI":"10.3389\/fphar.2022.914153","volume":"13","author":"LY Tong","year":"2022","unstructured":"Tong LY, Deng YB, Du WH, Zhou WZ, Liao XY, Jiang X. Clemastine promotes differentiation of oligodendrocyte progenitor cells through the activation of ERK1\/2 via muscarinic receptors after spinal cord injury. Front Pharmacol. 2022;13:914153.","journal-title":"Front Pharmacol"},{"issue":"5","key":"1428_CR68","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s12264-015-1537-5","volume":"31","author":"Y Chen","year":"2015","unstructured":"Chen Y, Mei R, Teng P, Yang A, Hu X, Zhang Z, Qiu M, Zhao X. TAPP1 inhibits the differentiation of oligodendrocyte precursor cells via suppressing the Mek\/Erk pathway. Neurosci Bull. 2015;31(5):517\u201326.","journal-title":"Neurosci Bull"},{"issue":"6","key":"1428_CR69","doi-asserted-by":"publisher","first-page":"e21058","DOI":"10.1371\/journal.pone.0021058","volume":"6","author":"X Liu","year":"2011","unstructured":"Liu X, Li Y, Zhang Y, Lu Y, Guo W, Liu P, Zhou J, Xiang Z, He C. SHP-2 promotes the maturation of oligodendrocyte precursor cells through Akt and ERK1\/2 signaling in vitro. PLoS One. 2011;6(6):e21058.","journal-title":"PLoS One"},{"issue":"5","key":"1428_CR70","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1471-4159.2009.06071.x","volume":"109","author":"O Bibollet-Bahena","year":"2009","unstructured":"Bibollet-Bahena O, Almazan G. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K\/mTOR\/Akt and MEK\/ERK pathways. J Neurochem. 2009;109(5):1440\u201351.","journal-title":"J Neurochem"},{"issue":"2","key":"1428_CR71","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neures.2012.12.004","volume":"75","author":"T Sasaki","year":"2013","unstructured":"Sasaki T. The axon as a unique computational unit in neurons. Neurosci Res. 2013;75(2):83\u20138.","journal-title":"Neurosci Res"},{"key":"1428_CR72","doi-asserted-by":"publisher","first-page":"102722","DOI":"10.1016\/j.conb.2023.102722","volume":"80","author":"S Li","year":"2023","unstructured":"Li S, Sheng Z-H. Oligodendrocyte-derived transcellular signaling regulates axonal energy metabolism. Curr Opin Neurobiol. 2023;80:102722.","journal-title":"Curr Opin Neurobiol"},{"issue":"2","key":"1428_CR73","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neuron.2014.10.019","volume":"84","author":"S Maday","year":"2014","unstructured":"Maday S, Twelvetrees AE, Moughamian AJ, Holzbaur EL. Axonal transport: cargo-specific mechanisms of motility and regulation. Neuron. 2014;84(2):292\u2013309.","journal-title":"Neuron"},{"key":"1428_CR74","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","volume":"246","author":"RE Burke","year":"2013","unstructured":"Burke RE, O\u2019Malley K. Axon degeneration in Parkinson\u2019s disease. Exp Neurol. 2013;246:72\u201383.","journal-title":"Exp Neurol"},{"issue":"2","key":"1428_CR75","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","volume":"29","author":"W Matsuda","year":"2009","unstructured":"Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R, Kaneko T. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci. 2009;29(2):444\u201353.","journal-title":"J Neurosci"},{"issue":"2","key":"1428_CR76","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.expneurol.2006.08.015","volume":"203","author":"CL Liang","year":"2007","unstructured":"Liang CL, Wang TT, Luby-Phelps K, German DC. Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson\u2019s disease. Exp Neurol. 2007;203(2):370\u201380.","journal-title":"Exp Neurol"},{"issue":"19","key":"1428_CR77","doi-asserted-by":"publisher","first-page":"7212","DOI":"10.1523\/JNEUROSCI.0711-11.2011","volume":"31","author":"JS Kim-Han","year":"2011","unstructured":"Kim-Han JS, Antenor-Dorsey JA, O\u2019Malley KL. The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons. J Neurosci. 2011;31(19):7212\u201321.","journal-title":"J Neurosci"},{"issue":"1","key":"1428_CR78","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0304-3940(99)00208-6","volume":"265","author":"H Braak","year":"1999","unstructured":"Braak H, Sandmann-Keil D, Gai W, Braak E. Extensive axonal Lewy neurites in Parkinson\u2019s disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci Lett. 1999;265(1):67\u20139.","journal-title":"Neurosci Lett"},{"issue":"Pt 7","key":"1428_CR79","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/brain\/aws133","volume":"135","author":"Y Chu","year":"2012","unstructured":"Chu Y, Morfini GA, Langhamer LB, He Y, Brady ST, Kordower JH. Alterations in axonal transport motor proteins in sporadic and experimental Parkinson\u2019s disease. Brain. 2012;135(Pt 7):2058\u201373.","journal-title":"Brain"},{"issue":"1","key":"1428_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-150769","volume":"6","author":"P Tagliaferro","year":"2016","unstructured":"Tagliaferro P, Burke RE. Retrograde axonal degeneration in parkinson disease. J Parkinsons Dis. 2016;6(1):1\u201315.","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"1428_CR81","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","volume":"29","author":"CY Chung","year":"2009","unstructured":"Chung CY, Koprich JB, Siddiqi H, Isacson O. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy. J Neurosci. 2009;29(11):3365\u201373.","journal-title":"J Neurosci"},{"key":"1428_CR82","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.nbd.2015.07.009","volume":"82","author":"P Tagliaferro","year":"2015","unstructured":"Tagliaferro P, Kareva T, Oo TF, Yarygina O, Kholodilov N, Burke RE. An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease. Neurobiol Dis. 2015;82:359\u201371.","journal-title":"Neurobiol Dis"},{"issue":"9","key":"1428_CR83","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/nn.2603","volume":"13","author":"K Liu","year":"2010","unstructured":"Liu K, Lu Y, Lee JK, Samara R, Willenberg R, Sears-Kraxberger I, Tedeschi A, Park KK, Jin D, Cai B, Xu B, Connolly L, Steward O, Zheng B, He Z. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat Neurosci. 2010;13(9):1075\u201381.","journal-title":"Nat Neurosci"},{"issue":"5903","key":"1428_CR84","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1126\/science.1161566","volume":"322","author":"KK Park","year":"2008","unstructured":"Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, Xu B, Connolly L, Kramvis I, Sahin M, He Z. Promoting axon regeneration in the adult CNS by modulation of the PTEN\/mTOR pathway. Science. 2008;322(5903):963\u20136.","journal-title":"Science"},{"issue":"1","key":"1428_CR85","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/mds.27209","volume":"33","author":"S Padmanabhan","year":"2018","unstructured":"Padmanabhan S, Burke RE. Induction of axon growth in the adult brain: a new approach to restoration in Parkinson\u2019s disease. Mov Disord. 2018;33(1):62\u201370.","journal-title":"Mov Disord"},{"issue":"1","key":"1428_CR86","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tins.2023.11.003","volume":"47","author":"LK Festa","year":"2024","unstructured":"Festa LK, Grinspan JB, Jordan-Sciutto KL. White matter injury across neurodegenerative disease. Trends Neurosci. 2024;47(1):47\u201357.","journal-title":"Trends Neurosci"},{"issue":"2","key":"1428_CR87","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.neuroscience.2009.12.040","volume":"166","author":"Y Pang","year":"2010","unstructured":"Pang Y, Campbell L, Zheng B, Fan L, Cai Z, Rhodes P. Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience. 2010;166(2):464\u201375.","journal-title":"Neuroscience"},{"issue":"5","key":"1428_CR88","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/jnen\/62.5.441","volume":"62","author":"RL Haynes","year":"2003","unstructured":"Haynes RL, Folkerth RD, Keefe RJ, Sung I, Swzeda LI, Rosenberg PA, Volpe JJ, Kinney HC. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol. 2003;62(5):441\u201350.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1428_CR89","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuroscience.2017.10.050","volume":"403","author":"M Haghshomar","year":"2019","unstructured":"Haghshomar M, Rahmani F, HadiAarabi M, Shahjouei S, Sobhani S, Rahmani M. White matter changes correlates of peripheral neuroinflammation in patients with Parkinson\u2019s disease. Neuroscience. 2019;403:70\u20138.","journal-title":"Neuroscience"},{"issue":"1","key":"1428_CR90","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12868-017-0367-y","volume":"18","author":"PL Chiang","year":"2017","unstructured":"Chiang PL, Chen HL, Lu CH, Chen PC, Chen MH, Yang IH, Tsai NW, Lin WC. White matter damage and systemic inflammation in Parkinson\u2019s disease. BMC Neurosci. 2017;18(1):48.","journal-title":"BMC Neurosci"},{"issue":"2","key":"1428_CR91","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0165-3806(02)00606-5","volume":"140","author":"Y Pang","year":"2003","unstructured":"Pang Y, Cai Z, Rhodes PG. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Dev Brain Res. 2003;140(2):205\u201314.","journal-title":"Dev Brain Res"},{"key":"1428_CR92","doi-asserted-by":"publisher","first-page":"100871","DOI":"10.1016\/j.mam.2020.100871","volume":"78","author":"MA Altinoz","year":"2021","unstructured":"Altinoz MA, Elmaci \u0130, Hacimuftuoglu A, Ozpinar A, Hacker E, Ozpinar A. PPAR\u03b4 and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson\u2019s disease. Mol Aspects Med. 2021;78:100871.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"1428_CR93","first-page":"e00025","volume":"2","author":"M Vittoria Simonini","year":"2010","unstructured":"Vittoria Simonini M, Polak PE, Boullerne AI, Peters JM, Richardson JC, Feinstein DL. Regulation of oligodendrocyte progenitor cell maturation by PPAR\u03b4: effects on bone morphogenetic proteins. ASN Neuro. 2010;2(1):e00025.","journal-title":"ASN Neuro"},{"key":"1428_CR94","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuroscience.2013.02.058","volume":"240","author":"HL Martin","year":"2013","unstructured":"Martin HL, Mounsey RB, Sathe K, Mustafa S, Nelson MC, Evans RM, Teismann P. A peroxisome proliferator-activated receptor-\u03b4 agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. Neuroscience. 2013;240:191\u2013203.","journal-title":"Neuroscience"},{"issue":"21","key":"1428_CR95","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1016\/j.neuron.2021.08.011","volume":"109","author":"KA Chamberlain","year":"2021","unstructured":"Chamberlain KA, Huang N, Xie Y, LiCausi F, Li S, Li Y, Sheng Z-H. Oligodendrocytes enhance axonal energy metabolism by deacetylation of mitochondrial proteins through transcellular delivery of SIRT2. Neuron. 2021;109(21):3456-3472.e8.","journal-title":"Neuron"},{"issue":"1","key":"1428_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2005.03168.x","volume":"94","author":"K Pierre","year":"2005","unstructured":"Pierre K, Pellerin L. Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem. 2005;94(1):1\u201314.","journal-title":"J Neurochem"},{"issue":"7408","key":"1428_CR97","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11314","volume":"487","author":"Y Lee","year":"2012","unstructured":"Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A, Jin L, Zhang PW, Pellerin L, Magistretti PJ, Rothstein JD. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487(7408):443\u20138.","journal-title":"Nature"},{"key":"1428_CR98","doi-asserted-by":"publisher","first-page":"104883","DOI":"10.1016\/j.neuint.2020.104883","volume":"141","author":"S Ravera","year":"2020","unstructured":"Ravera S, Morelli AM, Panfoli I. Myelination increases chemical energy support to the axon without modifying the basic physicochemical mechanism of nerve conduction. Neurochem Int. 2020;141:104883.","journal-title":"Neurochem Int"},{"issue":"7","key":"1428_CR99","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cub.2012.02.043","volume":"22","author":"MA Avery","year":"2012","unstructured":"Avery MA, Rooney TM, Pandya JD, Wishart TM, Gillingwater TH, Geddes JW, Sullivan PG, Freeman MR. WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering. Curr Biol. 2012;22(7):596\u2013600.","journal-title":"Curr Biol"},{"issue":"4","key":"1428_CR100","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.cub.2004.01.053","volume":"14","author":"A Sajadi","year":"2004","unstructured":"Sajadi A, Schneider BL, Aebischer P. Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. Curr Biol. 2004;14(4):326\u201330.","journal-title":"Curr Biol"},{"issue":"1","key":"1428_CR101","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.expneurol.2006.05.017","volume":"202","author":"DM Hasbani","year":"2006","unstructured":"Hasbani DM, O\u2019Malley KL. Wld(S) mice are protected against the Parkinsonian mimetic MPTP. Exp Neurol. 2006;202(1):93\u20139.","journal-title":"Exp Neurol"},{"key":"1428_CR102","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1326-7-5","volume":"7","author":"JA Antenor-Dorsey","year":"2012","unstructured":"Antenor-Dorsey JA, O\u2019Malley KL. WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity. Mol Neurodegener. 2012;7:5.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"1428_CR103","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.neuroimage.2012.06.012","volume":"62","author":"CL Rae","year":"2012","unstructured":"Rae CL, Correia MM, Altena E, Hughes LE, Barker RA, Rowe JB. White matter pathology in Parkinson\u2019s disease: the effect of imaging protocol differences and relevance to executive function. Neuroimage. 2012;62(3):1675\u201384.","journal-title":"Neuroimage"},{"key":"1428_CR104","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2019.07.019","volume":"66","author":"SJ Chung","year":"2019","unstructured":"Chung SJ, Lee YH, Yoo HS, Oh JS, Kim JS, Ye BS, Sohn YH, Lee PH. White matter hyperintensities as a predictor of freezing of gait in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2019;66:105\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1428_CR105","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/archneur.1995.00540260097023","volume":"52","author":"P Piccini","year":"1995","unstructured":"Piccini P, Pavese N, Canapicchi R, Paoli C, Del Dotto P, Puglioli M, Rossi G, Bonuccelli U. White matter hyperintensities in Parkinson\u2019s disease. Clinical correlations. Arch Neurol. 1995;52(2):191\u20134.","journal-title":"Arch Neurol"},{"issue":"6","key":"1428_CR106","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/mds.28510","volume":"36","author":"SH Jeong","year":"2021","unstructured":"Jeong SH, Lee HS, Jung JH, Baik K, Lee YH, Yoo HS, Sohn YH, Chung SJ, Lee PH. White matter hyperintensities, dopamine loss, and motor deficits in de novo Parkinson\u2019s disease. Mov Disord. 2021;36(6):1411\u20139.","journal-title":"Mov Disord"},{"issue":"3","key":"1428_CR107","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3233\/JPD-181351","volume":"8","author":"M Ciliz","year":"2018","unstructured":"Ciliz M, Sartor J, Lindig T, Pilotto A, Sch\u00e4ffer E, Weiss M, Scheltens P, Becker S, Hobert MA, Berg D, Liepelt-Scarfone I, Maetzler W. Brain-area specific white matter hyperintensities: associations to falls in Parkinson\u2019s disease. J Parkinsons Dis. 2018;8(3):455\u201362.","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"1428_CR108","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00702-015-1470-9","volume":"123","author":"B Vesel\u00fd","year":"2016","unstructured":"Vesel\u00fd B, Antonini A, Rektor I. The contribution of white matter lesions to Parkinson\u2019s disease motor and gait symptoms: a critical review of the literature. J Neural Transm (Vienna). 2016;123(3):241\u201350.","journal-title":"J Neural Transm (Vienna)"},{"issue":"Pt 1","key":"1428_CR109","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/brain\/awq343","volume":"134","author":"KF de Laat","year":"2011","unstructured":"de Laat KF, Tuladhar AM, van Norden AG, Norris DG, Zwiers MP, de Leeuw FE. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain. 2011;134(Pt 1):73\u201383.","journal-title":"Brain"},{"issue":"14","key":"1428_CR110","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1097\/WNR.0b013e32833ce5f1","volume":"21","author":"PM Schweder","year":"2010","unstructured":"Schweder PM, Hansen PC, Green AL, Quaghebeur G, Stein J, Aziz TZ. Connectivity of the pedunculopontine nucleus in parkinsonian freezing of gait. NeuroReport. 2010;21(14):914\u20136.","journal-title":"NeuroReport"},{"issue":"3","key":"1428_CR111","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12311-018-0988-4","volume":"18","author":"K Bharti","year":"2019","unstructured":"Bharti K, Suppa A, Pietracupa S, Upadhyay N, Giann\u00ec C, Leodori G, Di Biasio F, Modugno N, Petsas N, Grillea G, Zampogna A, Berardelli A, Pantano P. Abnormal cerebellar connectivity patterns in patients with Parkinson\u2019s disease and freezing of gait. Cerebellum. 2019;18(3):298\u2013308.","journal-title":"Cerebellum"},{"issue":"Pt 9","key":"1428_CR112","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/brain\/awh553","volume":"128","author":"ND Prins","year":"2005","unstructured":"Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, Hofman A, Breteler MM. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain. 2005;128(Pt 9):2034\u201341.","journal-title":"Brain"},{"issue":"2","key":"1428_CR113","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/1533317512470207","volume":"28","author":"B Deng","year":"2013","unstructured":"Deng B, Zhang Y, Wang L, Peng K, Han L, Nie K, Yang H, Zhang L, Wang J. Diffusion tensor imaging reveals white matter changes associated with cognitive status in patients with Parkinson\u2019s disease. Am J Alzheimers Dis Other Demen. 2013;28(2):154\u201364.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"1428_CR114","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.parkreldis.2018.10.015","volume":"61","author":"MT Grey","year":"2019","unstructured":"Grey MT, Vesel\u00fd B, Gajdo\u0161 M, Klobu\u0161iakov\u00e1 P, Rektor I. Contribution of white matter lesions to cognitive decline in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2019;61:248\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"1428_CR115","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00401-009-0620-2","volume":"119","author":"SA Choi","year":"2010","unstructured":"Choi SA, Evidente VG, Caviness JN, Shill HA, Sabbagh MN, Connor DJ, Hentz JG, Adler CH, Beach TG. Are there differences in cerebral white matter lesion burdens between Parkinson\u2019s disease patients with or without dementia? Acta Neuropathol. 2010;119(1):147\u20139.","journal-title":"Acta Neuropathol"},{"key":"1428_CR116","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.parkreldis.2021.11.010","volume":"93","author":"M Nazmuddin","year":"2021","unstructured":"Nazmuddin M, van Dalen JW, Borra RJH, Stormezand GN, van der Horn HJ, van der Zee S, Boertien J, van Laar T. Postural and gait symptoms in de novo Parkinson\u2019s disease patients correlate with cholinergic white matter pathology. Parkinsonism Relat Disord. 2021;93:43\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"1428_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2022.02.020","volume":"97","author":"SH Jeong","year":"2022","unstructured":"Jeong SH, Lee HS, Jung JH, Baik K, Sohn YH, Chung SJ, Lee PH. Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-na\u00efve Parkinson\u2019s disease. Parkinsonism Relat Disord. 2022;97:1\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1428_CR118","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/ene.13797","volume":"26","author":"LM Chahine","year":"2019","unstructured":"Chahine LM, Dos Santos C, Fullard M, Scordia C, Weintraub D, Erus G, Rosenthal L, Davatzikos C, McMillan CT. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson\u2019s disease. Eur J Neurol. 2019;26(2):246-e18.","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"1428_CR119","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.1016\/j.parkreldis.2015.09.019","volume":"22","author":"B Vesel\u00fd","year":"2016","unstructured":"Vesel\u00fd B, Rektor I. The contribution of white matter lesions (WML) to Parkinson\u2019s disease cognitive impairment symptoms: a critical review of the literature. Parkinsonism Relat Disord. 2016;22(Suppl 1):S166-70.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"1428_CR120","doi-asserted-by":"publisher","first-page":"11751","DOI":"10.1038\/s41598-021-91391-0","volume":"11","author":"M Nazmuddin","year":"2021","unstructured":"Nazmuddin M, Philippens IHCHM, van Laar T. Electrical stimulation of the nucleus basalis of meynert: a systematic review of preclinical and clinical data. Sci Rep. 2021;11(1):11751.","journal-title":"Sci Rep"},{"issue":"4","key":"1428_CR121","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","volume":"129","author":"AKL Liu","year":"2015","unstructured":"Liu AKL, Chang RC-C, Pearce RKB, Gentleman SM. Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson\u2019s disease. Acta Neuropathol. 2015;129(4):527\u201340.","journal-title":"Acta Neuropathol"},{"key":"1428_CR122","doi-asserted-by":"publisher","first-page":"106243","DOI":"10.1016\/j.nbd.2023.106243","volume":"185","author":"RA Crockett","year":"2023","unstructured":"Crockett RA, Wilkins KB, Aditham S, Bront\u00eb-Stewart HM. No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson\u2019s disease-related cognitive impairment. Neurobiol Dis. 2023;185:106243.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"1428_CR123","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1136\/jnnp.2003.031237","volume":"75","author":"A Br\u00fcck","year":"2004","unstructured":"Br\u00fcck A, Kurki T, Kaasinen V, Vahlberg T, Rinne JO. Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson\u2019s disease is related to cognitive impairment. J Neurol Neurosurg Psychiatry. 2004;75(10):1467\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"1428_CR124","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/1073858404266776","volume":"10","author":"AM Owen","year":"2004","unstructured":"Owen AM. Cognitive dysfunction in Parkinson\u2019s disease: the role of frontostriatal circuitry. Neuroscientist. 2004;10(6):525\u201337.","journal-title":"Neuroscientist"},{"issue":"4","key":"1428_CR125","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.neuroimage.2003.12.005","volume":"21","author":"MF Schocke","year":"2004","unstructured":"Schocke MF, Seppi K, Esterhammer R, Kremser C, Mair KJ, Czermak BV, Jaschke W, Poewe W, Wenning GK. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson\u2019s disease. Neuroimage. 2004;21(4):1443\u201351.","journal-title":"Neuroimage"},{"issue":"3","key":"1428_CR126","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/jnnp-2011-300872","volume":"83","author":"J Shin","year":"2012","unstructured":"Shin J, Choi S, Lee JE, Lee HS, Sohn YH, Lee PH. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson\u2019s disease patients according to cognitive status. J Neurol Neurosurg Psychiatry. 2012;83(3):315\u201321.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2\u20133","key":"1428_CR127","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000489311","volume":"18","author":"JY Lee","year":"2018","unstructured":"Lee JY, Kim JS, Jang W, Park J, Oh E, Youn J, Park S, Cho JW. Association between white matter lesions and non-motor symptoms in Parkinson disease. Neurodegener Dis. 2018;18(2\u20133):127\u201332.","journal-title":"Neurodegener Dis"},{"issue":"4","key":"1428_CR128","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13760-018-0937-5","volume":"118","author":"F Ghazi Sherbaf","year":"2018","unstructured":"Ghazi Sherbaf F, Same K, Aarabi MH. High angular resolution diffusion imaging correlates of depression in Parkinson\u2019s disease: a connectometry study. Acta Neurol Belg. 2018;118(4):573\u20139.","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"1428_CR129","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/82959","volume":"4","author":"J O'Doherty","year":"2001","unstructured":"O\u2019Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci. 2001;4(1):95\u2013102.","journal-title":"Nat Neurosci"},{"issue":"9","key":"1428_CR130","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s00415-006-0236-6","volume":"254","author":"H Matsui","year":"2007","unstructured":"Matsui H, Nishinaka K, Oda M, Niikawa H, Komatsu K, Kubori T, Udaka F. Depression in Parkinson\u2019s disease. Diffusion tensor imaging study. J Neurol. 2007;254(9):1170\u20133.","journal-title":"J Neurol"},{"issue":"1\u20132","key":"1428_CR131","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jns.2011.05.036","volume":"310","author":"VS Kosti\u0107","year":"2011","unstructured":"Kosti\u0107 VS, Filippi M. Neuroanatomical correlates of depression and apathy in Parkinson\u2019s disease: magnetic resonance imaging studies. J Neurol Sci. 2011;310(1\u20132):61\u20133.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"1428_CR132","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jns.2012.07.021","volume":"322","author":"IN Petrovic","year":"2012","unstructured":"Petrovic IN, Stefanova E, Kozic D, Semnic R, Markovic V, Daragasevic NT, Kostic VS. White matter lesions and depression in patients with Parkinson\u2019s disease. J Neurol Sci. 2012;322(1\u20132):132\u20136.","journal-title":"J Neurol Sci"},{"issue":"1","key":"1428_CR133","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41531-021-00270-y","volume":"8","author":"R Bhome","year":"2022","unstructured":"Bhome R, Zarkali A, Thomas GEC, Iglesias JE, Cole JH, Weil RS. Thalamic white matter macrostructure and subnuclei volumes in Parkinson\u2019s disease depression. NPJ Parkinsons Dis. 2022;8(1):2.","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"1428_CR134","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/cns.12634","volume":"23","author":"LL Gao","year":"2017","unstructured":"Gao LL, Zhang JR, Chan P, Wu T. Levodopa effect on basal ganglia motor circuit in Parkinson\u2019s disease. CNS Neurosci Ther. 2017;23(1):76\u201386.","journal-title":"CNS Neurosci Ther"},{"issue":"12","key":"1428_CR135","doi-asserted-by":"publisher","first-page":"e2825","DOI":"10.1002\/brb3.2825","volume":"12","author":"J Du","year":"2022","unstructured":"Du J, Zhou X, Liang Y, Zhao L, Dai C, Zhong Y, Liu H, Liu G, Mo L, Tan C, Liu X, Chen L. Levodopa responsiveness and white matter alterations in Parkinson\u2019s disease: a DTI-based study and brain network analysis: a cross-sectional study. Brain Behav. 2022;12(12):e2825.","journal-title":"Brain Behav"},{"issue":"6","key":"1428_CR136","doi-asserted-by":"publisher","first-page":"166117","DOI":"10.1016\/j.bbadis.2021.166117","volume":"1867","author":"N Shahsavani","year":"2021","unstructured":"Shahsavani N, Kataria H, Karimi-Abdolrezaee S. Mechanisms and repair strategies for white matter degeneration in CNS injury and diseases. Biochim Biophys Acta (BBA)-Mol Basis Dis. 2021;1867(6):166117.","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Dis"},{"issue":"3","key":"1428_CR137","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/mds.28892","volume":"37","author":"D Yellajoshyula","year":"2022","unstructured":"Yellajoshyula D, Pappas SS, Dauer WT. Oligodendrocyte and extracellular matrix contributions to central nervous system motor function: implications for dystonia. Mov Disord. 2022;37(3):456\u201363.","journal-title":"Mov Disord"},{"issue":"6183","key":"1428_CR138","doi-asserted-by":"publisher","first-page":"1252304","DOI":"10.1126\/science.1252304","volume":"344","author":"EM Gibson","year":"2014","unstructured":"Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, Wood LS, Inema I, Miller SE, Bieri G, Zuchero JB, Barres BA, Woo PJ, Vogel H, Monje M. Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science. 2014;344(6183):1252304.","journal-title":"Science"},{"issue":"3","key":"1428_CR139","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.21581","volume":"65","author":"S Mi","year":"2009","unstructured":"Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, Zhang Y, Shields CB, Zhang Y, Miklasz S, Shea D, Mason J, Franklin RJ, Ji B, Shao Z, Ch\u00e9dotal A, Bernard F, Roulois A, Xu J, Jung V, Pepinsky B. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol. 2009;65(3):304\u201315.","journal-title":"Ann Neurol"},{"issue":"1","key":"1428_CR140","doi-asserted-by":"publisher","first-page":"AN20090033","DOI":"10.1042\/AN20090033","volume":"2","author":"MV Simonini","year":"2010","unstructured":"Simonini MV, Polak PE, Boullerne AI, Peters JM, Richardson JC, Feinstein DL. Regulation of oligodendrocyte progenitor cell maturation by PPAR\u03b4: effects on bone morphogenetic proteins. ASN Neuro. 2010;2(1):AN20090033.","journal-title":"ASN Neuro"},{"issue":"10","key":"1428_CR141","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0166-2236(02)02255-5","volume":"25","author":"MP Coleman","year":"2002","unstructured":"Coleman MP, Perry VH. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci. 2002;25(10):532\u20137.","journal-title":"Trends Neurosci"},{"issue":"3","key":"1428_CR142","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1471-4159.2010.06632.x","volume":"113","author":"HC Cheng","year":"2010","unstructured":"Cheng HC, Burke RE. The Wld(S) mutation delays anterograde, but not retrograde, axonal degeneration of the dopaminergic nigro-striatal pathway in vivo. J Neurochem. 2010;113(3):683\u201391.","journal-title":"J Neurochem"},{"issue":"1","key":"1428_CR143","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.22383","volume":"70","author":"SR Kim","year":"2011","unstructured":"Kim SR, Chen X, Oo TF, Kareva T, Yarygina O, Wang C, During M, Kholodilov N, Burke RE. Dopaminergic pathway reconstruction by Akt\/Rheb-induced axon regeneration. Ann Neurol. 2011;70(1):110\u201320.","journal-title":"Ann Neurol"},{"issue":"1","key":"1428_CR144","doi-asserted-by":"publisher","first-page":"52","DOI":"10.55782\/ane-2022-005","volume":"82","author":"MA Al-Griw","year":"2022","unstructured":"Al-Griw MA, Salter MG, Wood IC. Blocking of NF-kB\/p38 MAPK pathways mitigates oligodendrocyte pathology in a model of neonatal white matter injury. Acta Neurobiol Exp (Wars). 2022;82(1):52\u201364.","journal-title":"Acta Neurobiol Exp (Wars)"},{"issue":"3","key":"1428_CR145","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2174\/1570159X20666220830115018","volume":"21","author":"L Xiao","year":"2023","unstructured":"Xiao L, Wang M, Shi Y, Xu Y, Gao Y, Zhang W, Wu Y, Deng H, Pan W, Wang W, Sun H. Secondary white matter injury mediated by neuroinflammation after intracerebral hemorrhage and promising therapeutic strategies of targeting the NLRP3 inflammasome. Curr Neuropharmacol. 2023;21(3):669\u201386.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"1428_CR146","doi-asserted-by":"publisher","first-page":"1552127","DOI":"10.1155\/2021\/1552127","volume":"2021","author":"Y Ran","year":"2021","unstructured":"Ran Y, Su W, Gao F, Ding Z, Yang S, Ye L, Chen X, Tian G, Xi J, Liu Z. Curcumin ameliorates white matter injury after ischemic stroke by inhibiting microglia\/macrophage pyroptosis through NF-\u03baB suppression and NLRP3 inflammasome inhibition. Oxid Med Cell Longev. 2021;2021(1):1552127.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"1428_CR147","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1002\/glia.23963","volume":"69","author":"RK Holloway","year":"2021","unstructured":"Holloway RK, Ireland G, Sullivan G, Becher JC, Smith C, Boardman JP, Gressens P, Miron VE. Microglial inflammasome activation drives developmental white matter injury. Glia. 2021;69(5):1268\u201380.","journal-title":"Glia"},{"issue":"4","key":"1428_CR148","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/jnc.15987","volume":"167","author":"XW Pang","year":"2023","unstructured":"Pang XW, Chu YH, Zhou LQ, Chen M, You YF, Tang Y, Yang S, Zhang H, Xiao J, Deng G, Wang W, Shang K, Qin C, Tian DS. Trem2 deficiency attenuates microglial phagocytosis and autophagic-lysosomal activation in white matter hypoperfusion. J Neurochem. 2023;167(4):489\u2013504.","journal-title":"J Neurochem"},{"key":"1428_CR149","doi-asserted-by":"publisher","first-page":"632374","DOI":"10.3389\/fnagi.2021.632374","volume":"13","author":"Y Feng","year":"2021","unstructured":"Feng Y, Guo M, Zhao H, Han S, Hao Y, Yuan Y, Shen W, Sun J, Dong Q, Cui M. Dl-3-n-butylphthalide alleviates demyelination and improves cognitive function by promoting mitochondrial dynamics in white matter lesions. Front Aging Neurosci. 2021;13:632374.","journal-title":"Front Aging Neurosci"},{"key":"1428_CR150","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.expneurol.2017.02.015","volume":"292","author":"F Luo","year":"2017","unstructured":"Luo F, Herrup K, Qi X, Yang Y. Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis. Exp Neurol. 2017;292:21\u201334.","journal-title":"Exp Neurol"},{"issue":"6","key":"1428_CR151","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.molmed.2021.03.004","volume":"27","author":"X Palomer","year":"2021","unstructured":"Palomer X, Aguilar-Recarte D, Garc\u00eda R, Nistal JF, V\u00e1zquez-Carrera M. Sirtuins: to be or not to be in diabetic cardiomyopathy. Trends Mol Med. 2021;27(6):554\u201371.","journal-title":"Trends Mol Med"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-024-01428-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-024-01428-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-024-01428-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T14:13:12Z","timestamp":1741011192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-024-01428-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":151,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["1428"],"URL":"https:\/\/doi.org\/10.1007\/s11357-024-01428-1","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}